創薬アウトソーシングの市場規模 - ワークフロー・治療領域・薬剤タイプ・エンドユーザー別 - 地域別展望・競合戦略・セグメント予測 (～2033年)

世界の創薬アウトソーシングの市場規模は、2033年にかけて7.71％のCAGRで推移し、85億9,000万米ドルの規模に成長すると予測されています。

薬理、バイオテクノロジー、製薬など、さまざまな分野で新薬や治療薬を発掘する方法のひとつに、創薬アウトソーシングがあります。このアプローチは成功率が比較的低く、手間のかかる手順です。それにもかかわらず、業界では大小の事業者が新薬を開発し、薬剤の有効性の判断・保証に向けた臨床試験後の検証のために、それらを大手事業者に提供しています。

COVID-19は創薬業界に大きな影響を与えました。過去3年間、製薬会社やバイオテクノロジー企業からのワクチン探索の高い需要があったためです。強力な抗ウイルス薬を生み出すためには、医薬品研究に外部の力を借りることが不可欠になっています。バイオテクノロジーや製薬セクターの企業はCROへの研究委託を進めていたため、COVID-19は市場の成長に大きな影響を与えました。これらの業務には、in vitroおよびin vivoモデルを用いた基礎研究と、初期段階の臨床開発が含まれます。

当レポートでは、世界の創薬アウトソーシングの市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 促進要因・抑制要因・機会・課題の分析
• COVID-19の市場への影響

第5章 市場変数と見通し

• SWOT分析
• PESTEL分析
• ポーターのファイブフォース分析
• ヒートマップ分析

第6章 競合情勢

• 製造拠点の分布・販売エリア・製品タイプ
• M&A・提携・製品発売・協力

第7章 世界の創薬アウトソーシング市場：ワークフロー別

• 世界の市場規模のシェア・予測
• 標的バリデーション・機能インフォマティクス
• リード同定・候補の最適化
• 前臨床開発
• 標的同定・スクリーニング
• その他

第8章 世界の創薬アウトソーシング市場：治療領域別

• 世界の市場規模のシェア・予測
• 心臓血管
• 中枢神経系
• 胃腸
• 血液
• 呼吸器系
• 感染症
• 腫瘍
• 免疫
• その他

第9章 世界の創薬アウトソーシング市場：薬剤タイプ別

• 世界の市場規模のシェア・予測
• 低分子
• 高分子

第10章 世界の創薬アウトソーシング市場：エンドユーザー別

• 市場規模・市場シェアの推移・予測
• 製薬・バイオテクノロジー企業
• 学術機関
• その他

第11章 世界の創薬アウトソーシング市場の予測

• 市場規模・市場シェアの推移・予測

第12章 世界の創薬アウトソーシング市場：地域別

• 市場規模・市場シェアの推移・予測
• アジア太平洋
• 欧州
• 中東・アフリカ
• 北米
• ラテンアメリカ

第13章 企業プロファイル

• Charles River Laboratories
• Curia Global Inc.
• Dalton Pharma Service
• Dr. Reddy's Laboratories
• Discover X Corporation
• Laboratory Corporation of America
• Merck & Co
• Syngene International Ltd.
• TCG Life Science Pvt. Ltd.
• Thermo Fisher Scientific, Inc.
• その他

第14章 略語一覧

第15章 参考リンク

第16章 総論

第17章 調査範囲

Drug Discovery Outsourcing Market Introduction and Overview

According to SPER market research, Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033 state that the Drug Discovery Outsourcing Market is predicted to reach USD 8.59 billion by 2033 with a CAGR of 7.71%.

One way to uncover new medications or therapeutics in a variety of sectors, including pharmacology, biotechnology, and pharmaceuticals, is through drug discovery outsourcing. This approach has a relatively poor success rate in drug development and is a labor-intensive procedure. Nonetheless, both large and tiny producers in the industry create novel medications and provide them to well-known competitors for examination after clinical trials to determine and guarantee the medications' efficacy.

Because several pharmaceutical and biotech businesses have been in high demand for vaccine discovery over the last three years, COVID-19 has had a substantial influence on the drug discovery industry. Using outside help for drug research has become essential to creating potent anti-virus therapies. Because businesses in the biotech and pharmaceutical sectors were progressively outsourcing research efforts to CROs, COVID-19 had a major effect on the market's growth. These operations comprised basic research employing in vitro and in vivo models as well as early-stage clinical development.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Workflow, By Therapeutic Area, By Drug Type, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Charles River Laboratories, Curia Global Inc, Dalton Pharma Service, Discover X Corporation, Dr. Reddy's Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd, Thermo Fisher Scientific,Inc, TCG Life Science Pvt Ltd.

Drug Discovery Outsourcing Market Segmentation

By Workflow: Based on the Workflow, Global Drug Discovery Outsourcing Market is segmented as; Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Target Identification and Screening, Others.

By Therapeutic Area: Based on the Therapeutic Area, Global Drug Discovery Outsourcing Market is segmented as; Cardiovascular, Central Nervous System, Gastrointestinal, Hematology, Respiration System, Infectious Disease, Oncology, Immunology, Others

By Drug Type: Based on the Drug Type, Global Drug Discovery Outsourcing Market is segmented as; Small Molecules, Large Molecules.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Drug Discovery Outsourcing Market.

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Drug Discovery Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Drug Discovery Outsourcing Market

7. Global Drug Discovery Outsourcing Market, By Workflow(USD Million) 2020-2033

• 7.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2020-2026
• 7.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2027-2033
• 7.3. Target Validation and Functional Informatics
• 7.4. Lead Identification and Candidate Optimization
• 7.5. Preclinical Development
• 7.6. Target Identification and Screening
• 7.7. Others

8. Global Drug Discovery Outsourcing Market, By Therapeutic Area(USD Million) 2020-2033

• 8.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2020-2026)
• 8.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2027-2033)
• 8.3. Cardiovascular
• 8.4. Central Nervous System
• 8.5. Gastrointestinal
• 8.6. Haematology
• 8.7. Respiratory System
• 8.8. Infectious Disease
• 8.9. Oncology
• 8.10. Immunology
• 8.11. Others

9. Global Drug Discovery Outsourcing Market, By Drug Type (USD Million) 2020-2033

• 9.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2020-2026)
• 9.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2027-2033)
• 9.3. Small Molecules
• 9.4. Large Molecules

10. Global Drug Discovery Outsourcing Market, By End User (USD Million) 2020-2033

• 10.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2020-2026)
• 10.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2027-2033)
• 10.3. Pharmaceutical and Biotechnological Companies
• 10.4. Academia Institutions
• 10.5. Others

11. Global Drug Discovery Outsourcing Market Forecast, 2020-2033 (USD Million)

• 11.1. Global Drug Discovery Outsourcing Market Size and Market Share

12. Global Drug Discovery Outsourcing Market, By Region, 2020-2033 (USD Million)

• 12.1. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2020-2026)
• 12.2. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2027-2033)
• 12.3. Asia-Pacific
  • 12.3.1. Australia
  • 12.3.2. China
  • 12.3.3. India
  • 12.3.4. Japan
  • 12.3.5. South Korea
  • 12.3.6. Rest of Asia-Pacific
• 12.4. Europe
  • 12.4.1. France
  • 12.4.2. Germany
  • 12.4.3. Italy
  • 12.4.4. Spain
  • 12.4.5. United Kingdom
  • 12.4.6. Rest of Europe
• 12.5. Middle East and Africa
  • 12.5.1. Kingdom of Saudi Arabia
  • 12.5.2. United Arab Emirates
  • 12.5.3. Qatar
  • 12.5.4. South Africa
  • 12.5.5. Egypt
  • 12.5.6. Morocco
  • 12.5.7. Nigeria
  • 12.5.8. Rest of Middle-East and Africa
• 12.6. North America
  • 12.6.1. Canada
  • 12.6.2. Mexico
  • 12.6.3. United States
• 12.7. Latin America
  • 12.7.1. Argentina
  • 12.7.2. Brazil
  • 12.7.3. Rest of Latin America

13. Company Profile

• 13.1. Charles River Laboratories
  • 13.1.1. Company details
  • 13.1.2. Financial outlook
  • 13.1.3. Product summary
  • 13.1.4. Recent developments
• 13.2. Curia Global Inc.
  • 13.2.1. Company details
  • 13.2.2. Financial outlook
  • 13.2.3. Product summary
  • 13.2.4. Recent developments
• 13.3. Dalton Pharma Service
  • 13.3.1. Company details
  • 13.3.2. Financial outlook
  • 13.3.3. Product summary
  • 13.3.4. Recent developments
• 13.4. Dr. Reddy's Laboratories
  • 13.4.1. Company details
  • 13.4.2. Financial outlook
  • 13.4.3. Product summary
  • 13.4.4. Recent developments
• 13.5. Discover X Corporation
  • 13.5.1. Company details
  • 13.5.2. Financial outlook
  • 13.5.3. Product summary
  • 13.5.4. Recent developments
• 13.6. Laboratory Corporation of America
  • 13.6.1. Company details
  • 13.6.2. Financial outlook
  • 13.6.3. Product summary
  • 13.6.4. Recent developments
• 13.7. Merck & Co
  • 13.7.1. Company details
  • 13.7.2. Financial outlook
  • 13.7.3. Product summary
  • 13.7.4. Recent developments
• 13.8. Syngene International Ltd.
  • 13.8.1. Company details
  • 13.8.2. Financial outlook
  • 13.8.3. Product summary
  • 13.8.4. Recent developments
• 13.9. TCG Life Science Pvt. Ltd.
  • 13.9.1. Company details
  • 13.9.2. Financial outlook
  • 13.9.3. Product summary
  • 13.9.4. Recent developments
• 13.10. Thermo Fisher Scientific, Inc.
  • 13.10.1. Company details
  • 13.10.2. Financial outlook
  • 13.10.3. Product summary
  • 13.10.4. Recent developments
• 13.11. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope